Nuvectis Pharma Inc (NVCT) — Net Asset Quality Index
Nuvectis Pharma Inc (NVCT) has a Net Asset Quality Index of 67.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $35.59 Million minus total liabilities of $11.58 Million yields net assets of $24.01 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Nuvectis Pharma Inc balance sheet assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Nuvectis Pharma Inc Net Asset Quality Index Over Time (2020–2024)
This chart shows how Nuvectis Pharma Inc's Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the index stands at 67.5%, representing net assets of $24.01 Million against total assets of $35.59 Million USD. See Nuvectis Pharma Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Nuvectis Pharma Inc (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for Nuvectis Pharma Inc from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Nuvectis Pharma Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 52.2% | $9.71 Million | $18.61 Million | $8.89 Million | ▼ -11.4 pp |
| 2023 | 63.6% | $12.20 Million | $19.18 Million | $6.98 Million | ▼ -6.1 pp |
| 2022 | 69.7% | $14.22 Million | $20.41 Million | $6.19 Million | ▲ +235.0 pp |
| 2021 | -165.4% | $-11.01 Million | $6.66 Million | $17.66 Million | ▼ -265.2 pp |
| 2020 | 99.8% | $6.65 Million | $6.66 Million | $10.00K | — |